RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Experts

William Zule

Senior Fellow, Health Policy

Education

DrPH, University of Texas School of Public Health-Houston
MPH, University of Texas School of Public Health-Houston
BA, University of Texas-San Antonio


William Zule, DrPH, is a leading expert in community-based HIV prevention research. For more than 25 years, his research has focused on HIV and hepatitis C virus epidemiology and prevention.

Dr. Zule’s work suggests that better syringe designs may substantially reduce HIV infections from syringe sharing. He is currently working with two needle and syringe programs in Tajikistan to develop and test strategies for implementing the World Health Organization’s recommendations regarding the distribution of low dead space syringes to reduce hepatitis C virus and HIV transmission among people who inject drugs.

His early work helped clarify the context of indirect needle sharing in HIV risk among intravenous drug users. Dr. Zule has been a principal investigator, project director, and ethnographer on several large HIV prevention epidemiologic research projects. More recently, he has published a series of papers examining and assessing treatment readiness and entry among out-of-treatment drug users. Dr. Zule currently serves on the board of directors of the North Carolina Harm Reduction Association.

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics